Guidelines On The Diagnosis And Treatment For Acute Promyelocytic Leukemia: Associação Brasileira De Hematologia, Hemoterapia E Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013

dc.creatorPagnano K.B.B.
dc.creatorRego E.M.
dc.creatorRohr S.
dc.creatorChauffaille M.L.
dc.creatorJacomo R.H.
dc.creatorBittencourt R.
dc.creatorFirmato A.B.
dc.creatorFagundes E.M.
dc.creatorMelo R.A.M.
dc.creatorBernardo W.
dc.date2014
dc.date2015-06-25T17:52:53Z
dc.date2015-11-26T14:20:44Z
dc.date2015-06-25T17:52:53Z
dc.date2015-11-26T14:20:44Z
dc.date.accessioned2018-03-28T21:22:25Z
dc.date.available2018-03-28T21:22:25Z
dc.identifier
dc.identifierRevista Brasileira De Hematologia E Hemoterapia. Sociedade Brasileira De Hematologia E Hemoterapia, v. 36, n. 1, p. 71 - 92, 2014.
dc.identifier15168484
dc.identifier10.5581/1516-8484.20140018
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84897786053&partnerID=40&md5=fd68b75500accbfead025356a85c4f4c
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/86347
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/86347
dc.identifier2-s2.0-84897786053
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1244330
dc.description[No abstract available]
dc.description36
dc.description1
dc.description71
dc.description92
dc.descriptionSwerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, , IARC: Lyon
dc.descriptionRohr, S.S., Pelloso, L.A., Borgo, A., de Nadai, L.C., Yamamoto, M., Rego, E.M., Chauffaille, M.L., Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: Two additional cases with clinical and laboratorial peculiar presentations (2012) Med Oncol, 29 (4), pp. 2345-2347
dc.descriptionDe Lourdes, C.M., Borri, D., Proto-Siqueira, R., Moreira, E.S., Alberto, F.L., Acute promyelocytic leukemia with t(15;17): Frequency of additional clonal chromosome abnormalities and FLT3 (2008) Leuk Lymphoma, 49 (12), pp. 2387-2389
dc.descriptionGupta, S.K., Sazawal, S., Mahapatra, M., Saxena, R., Evaluation of PG-M3 antibody in the diagnosis of acute promyelocytic leukaemia (2010) Eur J Clin Invest, 40 (10), pp. 960-962
dc.descriptionDimov, N.D., Medeiros, L.J., Kantarjian, H.M., Cortes, J.E., Chang, K.S., Bueso-Ramos, C.E., Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: The M.D (2010) Cancer, 116 (2), pp. 369-376. , Anderson Cancer Center experience of 349 patients
dc.descriptionBrockman, S.R., Paternoster, S.F., Ketterling, R.P., Dewald, G.W., New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia (2003) Cancer Genet Cytogenet, 145 (2), pp. 144-151
dc.descriptionO'Connor, S.J., Forsyth, P.D., Dalal, S., Evans, P.A., Short, M.A., Shiach, C., The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody (1997) Br J Haematol, 99 (3), pp. 597-604
dc.descriptionSanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet (2009) Blood, 113 (9), pp. 1875-1891
dc.descriptionTallman, M.S., Altman, J.K., How I treat acute promyelocytic leukemia (2009) Blood, 114 (25), pp. 5126-5135
dc.descriptionChang, H., Kuo, M.C., Shih, L.Y., Dunn, P., Wang, P.N., Wu, J.H., Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia (2012) Eur J Haematol, 88 (4), pp. 321-328
dc.descriptionKim, D.Y., Lee, J.H., Lee, J.H., Kim, S.D., Lim, S.N., Choi, Y., Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia (2011) Leuk Res, 35 (2), pp. 152-158
dc.descriptionYanada, M., Matsushita, T., Asou, N., Kishimoto, Y., Tsuzuki, M., Maeda, Y., Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: Incidence, risk factors, and influence on outcome (2007) Eur J Haematol, 78 (3), pp. 213-219
dc.descriptionDally, N., Hoffman, R., Haddad, N., Sarig, G., Rowe, J.M., Brenner, B., Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients (2005) Thromb Res, 116 (2), pp. 109-114
dc.descriptionHiguchi, T., Shimizu, T., Mori, H., Niikura, H., Omine, M., Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia (1997) Hematol Oncol, 15 (4), pp. 209-217
dc.descriptionSanz, M.A., Lo Coco, F., Martín, G., Avvisati, G., Rayón, C., Barbui, T., Definition ofrelapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups (2000) Blood, 96 (4), pp. 1247-1253
dc.descriptionHuang, H., Qin, Y., Xu, R., You, X., Teng, R., Yang, L., Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks (2012) Leuk Res, 36 (7), pp. 841-845
dc.descriptionCandoni, A., Damiani, D., Michelutti, A., Masolini, P., Michieli, M., Michelutti, T., Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia (2003) Eur J Haematol, 71 (1), pp. 1-8
dc.descriptionSanz, M.A., Montesinos, P., Vellenga, E., Rayón, C., de la Serna, J., Parody, R., Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: Long-term outcome of the LPA99 multicenter study by the PETHEMA Group (2008) Blood, 112 (8), pp. 3130-3134
dc.descriptionKawai, Y., Watanabe, K., Kizaki, M., Murata, M., Kamata, T., Uchida, H., Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia (1994) Am J Hematol, 46 (3), pp. 184-188
dc.descriptionRego, E.M., Kim, H.T., Ruiz-Argüelles, G.J., Undurraga, M.S., Uriarte, M.R., Jacomo, R.H., Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL (2013) Blood, 121 (11), pp. 1935-1943
dc.descriptionDrapkin, R.L., Gee, T.S., Dowling, M.D., Arlin, Z., McKenzie, S., Kempin, S., Prophylactic heparin therapy in acute promyelocytic leukemia (1978) Cancer, 41 (6), pp. 2484-2490
dc.descriptionTallman, M.S., Kwaan, H.C., Reassessing the hemostatic disorder associated with acute promyelocytic leukemia (1992) Blood, 79 (3), pp. 543-553
dc.descriptionZhao, W., Wang, X., Guo, W., Qu, B., Wang, H., Shen, Z., Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-transretinoic acid or arsenic trioxide treatment (2000) Chin Med J (Engl), 113 (3), pp. 236-240
dc.descriptionEscudier, S.M., Kantarjian, H.M., Estey, E.H., Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid (1996) Leuk Lymphoma, 20 (5-6), pp. 435-439
dc.descriptionGoldberg, M.A., Ginsburg, D., Mayer, R.J., Stone, R.M., Maguire, M., Rosenthal, D.S., Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? (1987) Blood, 69 (1), pp. 187-191
dc.descriptionHoyle, C.F., Swirsky, D.M., Freedman, L., Hayhoe, F.G., Beneficial effect of heparin in the management of patients with APL (1988) Br J Haematol, 68 (3), pp. 283-289
dc.descriptionBernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G., Gemon, M.F., Acute promyelocytic leukemia: Results of treatment with daunorubicin (1973) Blood, 41 (4), pp. 489-496
dc.descriptionLengfelder, E., Hanfstein, B., Haferlach, C., Braess, J., Krug, U., Spiekermann, K., Outcome of elderly patients with acute promyelocytic leukemia: Results of the German Acute Myeloid Leukemia Cooperative Group (2013) Ann Hematol, 92 (1), pp. 41-52
dc.descriptionIland, H., Bradstock, K., Seymour, J., Hertzberg, M., Grigg, A., Taylor, K., Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia (2012) Haematologica, 97 (2), pp. 227-234
dc.descriptionAvvisati, G., Lo-Coco, F., Paoloni, F.P., Petti, M.C., Diverio, D., Vignetti, M., AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: Very long-term results and role of maintenance (2011) Blood, 117 (18), pp. 4716-4725
dc.descriptionAdès, L., Guerci, A., Raffoux, E., Sanz, M., Chevalier, P., Lapusan, S., Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans-retinoic acid and chemotherapy: The European Group APL experience (2010) Blood, 115 (9), pp. 1690-1696
dc.descriptionPagnano, K.B., de Carvalho, D.G., Lorand-Metze, I., Delamain, M.T., Miranda, E.C., de Souza, C.A., Treatment outcome of acute promyelocytic leukemia with modified aida protocol (2010) Adv Hematol, 2010, p. 672137
dc.descriptionShen, Z.X., Shi, Z.Z., Fang, J., Gu, B.W., Li, J.M., Zhu, Y.M., All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia (2004) Proc Natl Acad Sci U S A, 101 (15), pp. 5328-5335
dc.descriptionWang, H., Chen, X.Y., Wang, B.S., Rong, Z.X., Qi, H., Chen, H.Z., The efficacy and safety of arsenic trioxide with or without alltrans retinoic acid for the treatment of acute promyelocytic leukemia: A meta-analysis (2011) Leuk Res, 35 (9), pp. 1170-1177
dc.descriptionElemam, O., Abdelmoety, D., Acute promyelocytic leukemia, study of predictive factors for Differentiation Syndrome, single center experience (2013) J Egypt Natl Canc Inst, 25 (1), pp. 13-19
dc.descriptionBreccia, M., Mazzarella, L., Bagnardi, V., Disalvatore, D., Loglisci, G., Cimino, G., Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols (2012) Blood, 119 (1), pp. 49-54
dc.descriptionde Botton, S., Dombret, H., Sanz, M., Miguel, J.S., Caillot, D., Zittoun, R., Incidence, clinical features, and outcome of all transretinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group (1998) Blood, 92 (8), pp. 2712-2718
dc.descriptionSu, Y.C., Dunn, P., Shih, L.Y., Kuo, M.C., Chang, H., Wu, J.H., Retinoic acid syndrome in patients following the treatment of acute promyelocytic leukemia with all-trans retinoic acid (2009) Chang Gung Med J, 32 (5), pp. 535-542
dc.descriptionJeddi, R., Ghédira, H., Mnif, S., Gouider, E., Fenaux, P., Meddeb, B., High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia (2010) Leuk Res, 34 (4), pp. 545-547
dc.descriptionMontesinos, P., Bergua, J.M., Vellenga, E., Rayón, C., Parody, R., de la Serna, J., León, A., Sanz, M.A., Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: Characteristics, outcome, and prognostic factors (2009) Blood, 113 (4), pp. 775-783
dc.descriptionJeddi, R., Kacem, K., Ben Neji, H., Mnif, S., Gouider, E., Aissaoui, L., Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia (2008) Hematology, 13 (3), pp. 142-146
dc.descriptionMontesinos, P., Sanz, M., The differentiation syndrome in patients with acute promyelocytic leukemia: Experience of pethema group and review of the literature (2011) Mediterr J Hematol Infect Dis, 3 (1), pp. e2011059
dc.descriptionSastre, A., Gago, E., Baños, M., Gómez, E., Acute renal failure in the transretinóico syndrome (2007) Nefrologia, 27 (2), pp. 184-190
dc.descriptionVahdat, L., Maslak, P., Miller Jr., W.H., Eardley, A., Heller, G., Scheinberg, D.A., Early mortalidade and the the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low dose-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patient treated with all-trans retinoic acid (1994) Blood, 84 (11), pp. 3843-3849
dc.descriptionWiley, J.S., Firkin, F.C., Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukemia Study Group (1995) Leukemia, 9 (5), pp. 774-778
dc.descriptionSanz, M.A., Montesinos, P., Rayón, C., Holowiecka, A., de la Serna, J., Milone, G., Risk-adapted treatament of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: Further improvements in treatment outcome (2010) Blood, 115 (25), pp. 5137-5146
dc.descriptionde la Serna, J., Montesinos, P., Vellenga, E., Rayón, C., Parody, R., León, A., Causes e prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarrubicin (2008) Blood, 111 (7), pp. 3395-3402
dc.descriptionTiamkao, S., Sirijirachai, C., Pseudotumor cerebri caused by all-trans-retinoic acid: A case report (2000) J Med Assoc Thai, 83 (11), pp. 1420-1423
dc.descriptionMahmoud, H.H., Hurwitz, C.A., Roberts, W.M., Santana, V.M., Ribeiro, R.C., Krance, R.A., Tretinoin toxicity in children with acute promyelocytic leukaemia (1993) Lancet, 342 (8884), pp. 1394-1395
dc.descriptionSelleri, C., Pane, F., Notaro, R., Catalano, L., Santoro, L.E., Luciano, L., All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri (1996) Br J Haematol, 92 (4), pp. 937-940
dc.descriptionVisani, G., Bontempo, G., Manfroi, S., Pazzaglia, A., D'Alessandro, R., Tura, S., All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: A possible disease association (1996) Haematologica, 81 (2), pp. 152-154
dc.descriptionChen, H.Y., Tsai, R.K., Huang, S.M., ATRA-induced pseudotumour cerebri--one case report (1998) Kaohsiung J Med Sci, 14 (1), pp. 58-60
dc.descriptionSano, F., Tsuji, K., Kunika, N., Takeuchi, T., Oyama, K., Hasegawa, S., Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid (1998) Intern Med, 37 (6), pp. 546-549
dc.descriptionNaderi, S., Nukala, S., Marruenda, F., Kudarvalli, P., Koduri, P.R., Pseudotumour cerebri in acute promyelocytic leukemia: Improvement despite continued ATRA therapy (1999) Ann Hematol, 78 (7), pp. 333-334
dc.descriptionGalm, O., Fabry, U., Osieka, R., Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide (2000) Leukemia, 14 (2), pp. 343-344
dc.descriptionColucciello, M., Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia (2003) Arch Ophthalmol, 121 (7), pp. 1064-1065
dc.descriptionYeh, Y.C., Tang, H.F., Fang, I.M., Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia (2006) Jpn J Ophthalmol, 50 (3), pp. 295-296
dc.descriptionDixon, K.S., Hassoun, A., Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole (2010) J Am Pharm Assoc (2003), 50 (6), pp. 742-744
dc.descriptionMachner, B., Neppert, B., Paulsen, M., Hofmann, C., Sander, T., Helmchen, C., Pseudotumor cerebri as a reversible side effect of all-trans retinoic acid treatment in acute promyelocytic leukaemia (2008) Eur J Neurol, 15 (7), pp. e68-e69
dc.descriptionGallipoli, P., Drummond, M.W., Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia (2009) Eur J Haematol, 82 (3), pp. 242-243
dc.descriptionSchroeter, T., Lanvers, C., Herding, H., Suttorp, M., Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia (2000) Med Pediatr Oncol, 34 (4), pp. 284-286
dc.descriptionDecaudin, D., Adams, D., Naccache, P., Castagna, L., Munck, J.N., Maintained all-trans retinoic acid therapy in a patient with pseudotumour cerebri despite aggravated symptoms (1997) Leuk Lymphoma, 27 (3-4), pp. 373-374
dc.descriptionSpecchia, G., Lo Coco, F., Vignetti, M., Avvisati, G., Fazi, P., Albano, F., Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: A report by the Gruppo Italiano Malattie Ematologiche dell'Adulto (2001) J Clin Oncol, 19 (20), pp. 4023-4028
dc.descriptionKakimoto, T., Takahashi, Y., Watanabe, H., Matsuzawa, M., Sanada, Y., Primary multiple cerebral invasion in acute promyelocytic leukemia dramatically worsened by all-trans retinoic acid (2010) Leuk Res, 34 (5), pp. e137-e139
dc.descriptionde Botton, S., Sanz, M.A., Chevret, S., Dombret, H., Martin, G., Thomas, X., Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (2006) Leukemia, 20 (1), pp. 35-41
dc.descriptionAdès, L., Sanz, M.A., Chevret, S., Treatment of newly diagnosed acute promyelocytic leukemia (APL): A comparison of French-Belgian-Swiss and PETHEMA results (2007) Epub, p. 1
dc.descriptionAdès, L., Chevret, S., Raffoux, E., de Botton, S., Guerci, A., Pigneux, A., Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group (2006) J Clin Oncol, 24 (36), pp. 5703-5710
dc.descriptionSanz, M.A., Vellenga, E., Rayón, C., Díaz-Mediavilla, J., Rivas, C., Amutio, E., All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia (2004) Blood, 104 (12), pp. 3490-3493
dc.descriptionFenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group (1999) Blood, 94 (4), pp. 1192-1200
dc.descriptionSanz, M.A., Montesinos, P., Rayón, C., Holowiecka, A., de la Serna, J., Milone, G., Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: Further improvements in treatment outcome (2010) Blood, 115 (25), pp. 5137-5146
dc.descriptionSchlenk, R.F., Germing, U., Hartmann, F., Glasmacher, A., Fischer, J.T., Valle, D., Fuentes, F., High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia (2005) Leukemia, 19 (6), pp. 978-983
dc.descriptionde Botton, S., Fawaz, A., Chevret, S., Dombret, H., Thomas, X., Sanz, M., Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: A retrospective analysis of the European acute promyelocytic leukemia group (2005) J Clin Oncol, 23 (1), pp. 120-126
dc.descriptionSanz, M.A., Labopin, M., Gorin, N.C., de la Rubia, J., Arcese, W., Meloni, G., Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: A survey of the European Cooperative Group for Blood and Marrow Transplantation (2007) Bone Marrow Transplant, 39 (8), pp. 461-469
dc.descriptionDvorak, C.C., Agarwal, R., Dahl, G.V., Gregory, J.J., Feusner, J.H., Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia (2008) Biol Blood Marrow Transplant, 14 (7), pp. 824-830
dc.descriptionApperley, J., Carreras, E., Gluckman, E., Masszi, T., Hematopoietic Stem Cell Transplantation (2012) The EBMT Handbook
dc.descriptionChendamarai, E., Balasubramanian, P., George, B., Viswabandya, A., Abraham, A., Ahmed, R., Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy (2012) Blood, 119 (15), pp. 3413-3419
dc.descriptionPolampalli, S., Choughule, A., Prabhash, K., Amare, P., Baisane, C., Kabre, S., Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia (2011) Indian J Cancer, 48 (1), pp. 60-67
dc.descriptionLee, S., Kim, Y.J., Eom, K.S., Min, C.K., Kim, H.J., Cho, S.G., The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: Results of a prospective trial (2006) Haematologica, 91 (5), pp. 671-674
dc.descriptionLiu, Y.F., Zhu, Y.M., Shen, S.H., Shen, Z.X., Li, J.M., Chen, S.J., Molecular response in acute promyelocytic leukemia: A direct comparison of regular and real-time RT-PCR (2006) Leukemia, 20 (8), pp. 1393-1399
dc.descriptionSantamaría, C., Chillón, M.C., Fernández, C., Martín-Jiménez, P., Balanzategui, A., García, S.R., Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia (2007) Haematologica, 92 (3), pp. 315-322
dc.descriptionRaffoux, E., Rousselot, P., Poupon, J., Daniel, M.T., Cassinat, B., Delarue, R., Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia (2003) J Clin Oncol, 21 (12), pp. 2326-2334
dc.descriptionCarradice, D., Austin, N., Bayston, K., Ganly, P.S., Successful treatment of acute promyelocytic leukaemia during pregnancy (2002) Clin Lab Haematol, 24 (5), pp. 307-311
dc.descriptionYang, D., Hladnik, L., Treatment of acute promyelocytic leukemia during pregnancy (2009) Pharmacotherapy, 29 (6), pp. 709-724
dc.descriptionWatanabe, R., Okamoto, S., Moriki, T., Kizaki, M., Kawai, Y., Ikeda, Y., Treatment of acute promyelocytic leukemia with all-trans retinoic acid during the third trimester of pregnancy (1995) Am J Hematol, 48 (3), pp. 210-211
dc.descriptionRequena, A., Velasco, J.G., Pinilla, J., Gonzalez-Gonzalez, A., Acute leukemia during pregnancy: Obstetric management and perinatal outcome of two cases (1995) Eur J Obstet Gynecol Reprod Biol, 63 (2), pp. 139-141
dc.descriptionIncerpi, M.H., Miller, D.A., Posen, R., Byrne, J.D., All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy (1997) Obstet Gynecol, 89 (5 PART 2), pp. 826-828
dc.descriptionGiagounidis, A.A., Beckmann, M.W., Giagounidis, A.S., Aivado, M., Emde, T., Germing, U., Acute promyelocytic leukemia and pregnancy (2000) Eur J Haematol, 64 (4), pp. 267-271
dc.descriptionFadilah, S.A., Hatta, A.Z., Keng, C.S., Jamil, M.A., Singh, S., Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid (2001) Leukemia, 15 (10), pp. 1665-1666
dc.descriptionNakamura, K., Dan, K., Iwakiri, R., Gomi, S., Nomura, T., Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid (1995) Ann Hematol, 71 (5), pp. 263-264
dc.descriptionLipovsky, M.M., Biesma, D.H., Christiaens, G.C., Petersen, E.J., Successful treatment of acute promyelocytic leukaemia with all-trans-retinoic-acid during late pregnancy (1996) Br J Haematol, 94 (4), pp. 699-701
dc.descriptionTerada, Y., Shindo, T., Endoh, A., Watanabe, M., Fukaya, T., Yajima, A., Fetal arrhythmia during treatment of pregnancy-associated acute promyelocytic leukemia with all-trans retinoic acid and favorable outcome (1997) Leukemia, 11 (3), pp. 454-455
dc.descriptionTakitani, K., Hino, N., Terada, Y., Kurosawa, Y., Koh, M., Inoue, A., Plasma all-trans retinoic acid level in neonates of mothers with acute promyelocytic leukemia (2005) Acta Haematol, 114 (3), pp. 167-169
dc.descriptionCulligan, D.J., Merriman, L., Kell, J., The management of acute promyelocytic leucemia presenting during pregnancy (2007) Clin Leukemia, 1, pp. 183-191
dc.descriptionCardonick, E., Iacobucci, A., Use of chemotherapy during human pregnancy (2004) Lancet Oncol, 5 (5), pp. 283-291
dc.descriptionSiu, B.L., Alonzo, M.R., Vargo, T.A., Fenrich, A.L., Trasient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans retinoic acid (ATRA) early in the second trimester of pregnancy (2002) Int J Gynecol Cancer, 12 (4), pp. 399-402
dc.descriptionTallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., All-trans retinoic acid in acute promyelocytic leukemia (1997) N Engl J Med, 337 (15), pp. 1201-1208
dc.descriptionLatagliata, R., Avvisati, G., Lo Coco, F., Petti, M.C., Diverio, D., Spadea, A., The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 years (1997) Ann Oncol, 8 (12), pp. 1273-1275
dc.descriptionSanz, M.A., Vellenga, E., Rayón, C., Díaz-Mediavilla, J., Rivas, C., Amutio, E., All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia (2004) Blood, 104 (12), pp. 3490-3493
dc.descriptionAdes, L., Chevret, S., de Botton, S., Thomas, X., Dombret, H., Beve, B., Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: The European group experience (2005) Leukemia, 19 (2), pp. 230-233. , European APL Group
dc.descriptionLatagliata, R., Breccia, M., Fazi, P., Vignetti, M., Di Raimondo, F., Sborgia, M., GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors (2011) Br J Haematol, 154 (5), pp. 564-568
dc.descriptionLengfelder, E., Hanfstein, B., Haferlach, C., Braess, J., Krug, U., Spiekermann, K., Outcome of elderly patients with acute promyelocytic leukemia: Results of the German Acute Myeloid Leukemia Cooperative Group (2013) Ann Hematol, 92 (1), pp. 41-52
dc.descriptionDiverio, D., Rossi, V., Avvisati, G., de Santis, S., Pistilli, A., Pane, F., Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/ RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial (1998) Blood, 92 (3), pp. 784-789
dc.descriptionSantamaría, C., Chillón, M.C., Fernández, C., Martín-Jiménez, P., Balanzategui, A., García, S.R., Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia (2007) Haematologica, 92 (3), pp. 315-322
dc.descriptionGrimwade, D., Jovanovic, J.V., Hills, R.K., Nugent, E.A., Patel, Y., Flora, R., Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy (2009) J Clin Oncol, 27 (22), pp. 3650-3658
dc.languageen
dc.publisherSociedade Brasileira de Hematologia e Hemoterapia
dc.relationRevista Brasileira de Hematologia e Hemoterapia
dc.rightsaberto
dc.sourceScopus
dc.titleGuidelines On The Diagnosis And Treatment For Acute Promyelocytic Leukemia: Associação Brasileira De Hematologia, Hemoterapia E Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución